MMP1 and MMP3 polymorphisms in promoter regions and cancer [8]

Clinical Chemistry

Volumn 46, Issue 12, 2000, Pages 2023-2024

  Biondi, M L ^a   Turri, O ^a   Leviti, S ^a   Seminati, R ^a   Cecchini, F ^a   Bernini, M ^a   Ghilardi, G ^a   Guagnellini, E ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; STROMELYSIN;

BREAST CANCER; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; LETTER; LUNG CANCER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PROMOTER REGION;

EID: 0033635555     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.12.2023     Document Type: Letter

References (7)

1. Changing views of the role of matrix metalloproteinases in metastasis
2. Distribution of collagenase and tissue inhibitor of metalloproteinase (TIMP) in colorectal tumors
3. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an ETS binding site and augments transcription
4. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region
5. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial cancer
6. The matrix metalloproteinase stromelysin-1 acts as natural mammary tumor promoter
7. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression